Bausch + Lomb to Participate in the 43rd Annual J.P. Morgan Healthcare Conference
Bausch + Lomb (NYSE/TSX: BLCO) has announced its participation in the 43rd Annual J.P. Morgan Healthcare Conference. The company's leadership team, including Chairman and CEO Brent Saunders, CFO Sam Eldessouky, and Chief Medical Officer and Head of R&D Yehia Hashad, M.D., will deliver a company presentation on Monday, January 13, 2025, at 11:15 a.m. PT (2:15 p.m. ET).
The global eye health company will provide a live webcast of the event, with an audio archive available afterward on their Investor Relations page at http://ir.bausch.com/investors/events-presentations.
Bausch + Lomb (NYSE/TSX: BLCO) ha annunciato la sua partecipazione al 43° Annuale J.P. Morgan Healthcare Conference. Il team di leadership dell'azienda, compreso il Presidente e CEO Brent Saunders, il CFO Sam Eldessouky e il Chief Medical Officer e Responsabile R&D Yehia Hashad, M.D., presenterà un intervento dell'azienda lunedì 13 gennaio 2025, alle 11:15 PT (14:15 ET).
La compagnia globale attiva nella salute oculare fornirà una diretta web dell'evento, con un archivio audio disponibile successivamente sulla loro pagina per gli Investitori all'indirizzo http://ir.bausch.com/investors/events-presentations.
Bausch + Lomb (NYSE/TSX: BLCO) ha anunciado su participación en la 43ª Conferencia Anual de Atención Médica J.P. Morgan. El equipo directivo de la compañía, incluyendo al Presidente y CEO Brent Saunders, al CFO Sam Eldessouky, y al Chief Medical Officer y Jefe de I+D Yehia Hashad, M.D., hará una presentación de la compañía el lunes 13 de enero de 2025, a las 11:15 a.m. PT (2:15 p.m. ET).
La compañía global de salud ocular proporcionará una transmisión en vivo del evento, con un archivo de audio disponible posteriormente en su página de Relaciones con Inversores en http://ir.bausch.com/investors/events-presentations.
바우슈 + 롬 (NYSE/TSX: BLCO)는 제43회 JP모건 헬스케어 컨퍼런스에 참여한다고 발표했습니다. 회사의 리더십 팀에는 회장 겸 CEO 브렌트 손더스, CFO 샘 엘데수키, 의료 책임자이자 연구개발 총괄 예히아 하샤드, M.D.가 포함되어 있으며, 2025년 1월 13일 월요일, 오전 11:15 PT(오후 2:15 ET)에 회사 발표를 진행할 예정입니다.
글로벌 안구 건강 회사는 이벤트의 라이브 웹캐스트를 제공하며, 그 후에는 투자자 관계 페이지 http://ir.bausch.com/investors/events-presentations에서 오디오 아카이브를 이용할 수 있습니다.
Bausch + Lomb (NYSE/TSX: BLCO) a annoncé sa participation à la 43e Conférence Annuelle J.P. Morgan Healthcare. L'équipe de direction de l'entreprise, comprenant le Président et CEO Brent Saunders, le CFO Sam Eldessouky, et le Médecin en Chef et Responsable R&D Yehia Hashad, M.D., fera une présentation de l'entreprise le lundi 13 janvier 2025, à 11h15 PT (14h15 ET).
La société mondiale de santé oculaire proposera une diffusion en direct de l'événement, avec un enregistrement audio disponible par la suite sur leur page des Relations Investisseurs à l'adresse http://ir.bausch.com/investors/events-presentations.
Bausch + Lomb (NYSE/TSX: BLCO) hat seine Teilnahme an der 43. J.P. Morgan Healthcare Conference bekannt gegeben. Das Führungsteam des Unternehmens, darunter Vorsitzender und CEO Brent Saunders, CFO Sam Eldessouky und Chefarzt und Leiter F&E Yehia Hashad, M.D., wird am Montag, den 13. Januar 2025, um 11:15 Uhr PT (14:15 Uhr ET) eine Unternehmenspräsentation halten.
Das globale Unternehmen für Augengesundheit wird eine Live-Übertragung der Veranstaltung anbieten, und danach steht ein Audio-Archiv auf ihrer Investor Relations-Seite unter http://ir.bausch.com/investors/events-presentations zur Verfügung.
- None.
- None.
A live webcast and audio archive of the event will be available on the Investor Relations page of the Bausch + Lomb website: http://ir.bausch.com/investors/events-presentations.
About Bausch + Lomb
Bausch + Lomb is dedicated to protecting and enhancing the gift of sight for millions of people around the world – from birth through every phase of life. Its comprehensive portfolio of approximately 400 products includes contact lenses, lens care products, eye care products, ophthalmic pharmaceuticals, over-the-counter products and ophthalmic surgical devices and instruments. Founded in 1853, Bausch + Lomb has a significant global research and development, manufacturing and commercial footprint with approximately 13,000 employees and a presence in nearly 100 countries. Bausch + Lomb is headquartered in
© 2025 Bausch + Lomb.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250102527361/en/
Media Contact:
Chris Clark
chris.clark@bausch.com
(848) 360-1100
Investor Contact:
George Gadkowski
george.gadkowski@bausch.com
(877) 354-3705 (toll free)
Source: Bausch + Lomb Corporation
FAQ
When is Bausch + Lomb (BLCO) presenting at the J.P. Morgan Healthcare Conference 2025?
How can investors watch Bausch + Lomb's (BLCO) J.P. Morgan Healthcare Conference presentation?
Which executives from Bausch + Lomb (BLCO) will present at the 2025 J.P. Morgan Healthcare Conference?
Will Bausch + Lomb's (BLCO) J.P. Morgan Healthcare Conference presentation be archived for later viewing?
